.16
Pubertal animals of 2-4 years had significantly higher values than younger or older animals (P<.001). There was a correlation of bodyweight with IGF-1 values in the males (~*=.717, p<.0005). This trend was confirmed in the longitudinal study. In conclusion, the rhesus monkey, like the human being, has higher IGF-1 values during the pubertal period, and should afford a useful model of IGF-1 regulation in human development. We examined a total of 37 children referred to the Pediatric Endocrine Clinic with either congenital adrenal hyperplasia (CAH) or idiopathic precocious puperty (IPP), utilizing educational history and selected objective testing instruments. Of the 15 patients with CAH, 6 (40%) had special educational needs. 5 of these were functioning below the normal range, and 1 was in an advanced program. Of the 24 patients referred with IPP, 1 1 (46%) were in remedial placements. 6 of this group had sufficiently severe cognitive deficits that they were felt to represevt neurogenic, rather than idiopathic, precocity. The percentage of chjldren in each group requiring special educational coqsideration is much higher than in the general population (approximately 12%).
This data is in contrast to previously published studies which documcnted elevated mean I ( ) scores in both CAH and IP?. Data on the educational and socio-economic background of those patients are not described. However, there were no discernable differences in socio-economic class, or level of parental education between the various groupings in our series. While conflicting, both the previous reports and our series argue that all children in whom either CAI1 or IPP are entertained as a diagrosis should receive fuil cognitive and educational assessment. Sci. USA, in press). However, the regulation of ICE-I1 in the testis is unknown. We detected IGF-I1 mRNA in Northern blots of RNA from fetal adrenal, placenta, liver, kidney, muscle and testis, but not ovary. In testes of 25 fetuses from 13 to 26 weeks gestation, the abundance of IGF-I1 mRNA closely followed the pattern shown for P450scc mRNA (R.V. and W.L.M., J. Clin. Endocrinol. Metab. 63:1145), with a peak at 14-15 weeks and diminishing thereafter. In 20 week gestation total testicular cells cultured with serum, 100 ng/ml hCG elicited no change in amounts of mRNAs for P450scc. P450c17 (17a-hydroxylase/l7,20 lyase) or IGF-11, while 1 mM CAMP increased P450scc and P450c17 mRNAs 10-fold, but did not change IGF-I1 mRNA. 100 ng/dl hCG increases P450scc and IGF-I1 mRNAs in cultured granulosa cells, and 1 mM CAMP induces accumulation of both mRNAs in fetal adrenal placenta and granulosa cells. Thus, in contradistinction to IGF-I1 mRNA in other steroidogenic tissues, fetal adrenal cells or placenta, fetal testicular IGF-I1 mRNA does not respond to factors stimulating steroid hormone synthesis, despite similar age-dependent regulation during gestation. ~o l~s o m n o~r a~h i c recordings were obtained in six patients with idiopathic short stature (ISS), aged 4-10112 to 16-1/2 yrs and seven patients with growth hormone deficiency (GHD) aged 6-3112 to 10-5112 yrs. ISS patients had GH levels 2 10 ng/ml and CHD patients had GH levels 5 7 ng/ml during provocative testing. Both groups had growth velocities below the 50th percenrile and all patients were euthyroid. The results of the polysomnographic recordings (mean + SD) are shown below for ISS, GHD and normals aged 6-13 yrs.
REGULATION OF mRNA FOR INSULIN-LIKE GROWTH FACTOR
PERCENT tively, poorer sleep with an average of 66.7 minutes of wake-time during the sleep period as compared with <10 min. in GHD and normals. There was no correlation between wake-time and mean GH concentrations or secretory rates, although some ISS patients had very low mean GH range (2.0-9.5 ng/ml) .
Conclusions: Sleep architecture is abnormal in ISS and is indistinguishable from that seen in GHD. Coupled with low mean GH seen in some ISS patients, these abnormalities may be the cause(s) for the growth retardation in ISS.
SALT LOSS AND MINETAXXDRPICOID RESISTANCE IN AN ACUTE EFFECT 07 AUTHENTIC (METHIONINE-FREE) HUMAN
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A;rinoam Kowarski*. Amnon ~o n e b n e * * * , *~a p ; a~; Fennessey, L . W k Harrison, Liniversity of Colorado 493 x t a l , Rehovot; hJniversity of Maryland School IUth. Sci. C t r . , Dept. of Ped., Wnver, Colorado of Medicine, Baltimore, MD; ***Bio-Technology Gis C h r a y t o g r a p h y~s s Spedmnetry (GC/MS) analysis of urinary steroid derlvatlves has extended our understanding of a vxiety of metabolic disease states. K/MS was used to evaluate a suspected case of adrenal hyperplasia. A 4 week-old male presentd with failure to thrive, absence of excessive virilization, hypnatrania (Na 120 m l h ) and hyperkalenic metzblic acidosis. S e m 17-and urinary 17-ketosteroids ard pregnanetriol were MA. Treatnwt with IV saline and IM DOCA resulted in imnprov~nent, h t a-fluoromrtisone alone was ineffective and NaCl supplanents at doses of &mml/kg/day were needed. Plasna aldosterone was 840 p l / L (27 ng/dL); PRA was 125ng/h1l/hr after 5 months of treatment. An older brother with salt losing in infancy had r e q m n d d to s o d i m and a-fluorocortisone and was considered to be an 18 hydroxylase m p l e x deficiency. GC analysis m n f W the normalcy of glucocorticoid and a n h e n wthwavs a s well a s an abnormal elevation of WE.
General, Rehovot, Tsrael. AhCH 0.1 mg/kg (Bio-Technology General-Israel, Ltd.) was administered subcutaneously to 8 healthy volunteers (27 to 47 yrs) every other day for one week (3 doses). The GH blood level reached a peak 5.751.8 hrs after the first injection of AhGH (mean 2 iSD). The peak GH level was 64.3211.4 ng/ml.
IGF-1 plasma concentration increased from 0.55+0.19 U/ml to 1.0820.17 after 24-hours and to 2.1 850.31 U/ml 24-hours after the third AhGH administration.
Morning blood samples obtained prior to the first AhGH injection, and following the third injection, revealed significant difference (P 0.05) in the following parameters: urea-decreased from 2726.8 to 22.328.1 mg/dl; glucose-increased from 90215 to 106214.7 mg/dl and cholesterol-decreased from 209260 to 117241 mg/dl. There were no significant effects on the blood count and differential, blood chemistry, or In addition, there k s a marked elevation of V4A (TH corticcsterol), confirmed by MS, which has not been previously reported.
In contrast with other cases of pseudohypaldosteronisn and abnormalities in aldosterone biosynthesis, the present canbination of features suggests problem in both aldosterone synthesis and tuhular insensitivity to mineralomrticoids. The latter may possibly result fran competitive inhibition by THA.
